Fresenius Medical Care AG & Co. KGaA (FME) Given a €84.20 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. set a €84.20 ($97.91) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report sent to investors on Friday. The brokerage currently has a buy rating on the stock.

Several other research firms have also commented on FME. Jefferies Financial Group set a €82.00 ($95.35) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research report on Monday, October 1st. Sanford C. Bernstein set a €107.00 ($124.42) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Monday, October 1st. Goldman Sachs Group set a €98.00 ($113.95) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Monday, October 1st. Deutsche Bank set a €107.00 ($124.42) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Friday, October 5th. Finally, Barclays set a €87.20 ($101.40) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research report on Friday, September 28th. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Fresenius Medical Care AG & Co. KGaA currently has an average rating of Buy and an average target price of €87.36 ($101.59).

FME opened at €62.24 ($72.37) on Friday. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €75.53 ($87.83) and a 12 month high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Recommended Story: Return on Investment (ROI) Defined, Explained

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply